Hearing Services, Ltd Audiologist Medicare: Not Enrolled in Medicare Practice Location: 13123 Eureka Rd, Southgate, MI 48195 Phone: 734-282-7991 |
Dr. Rhiannon Danielle Workman Mckay, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3 Heritage Dr Ste 1, Southgate, MI 48195 Phone: 248-756-0898 |
Roberta Michels, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 14500 Northline Rd, Southgate, MI 48195 Phone: 734-281-4197 Fax: 734-282-0093 |
Sharon B. Seal, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 13123 Eureka Rd, Southgate, MI 48195 Phone: 734-282-7991 |
Noel Rendleman Audiologist Medicare: Not Enrolled in Medicare Practice Location: 14500 Northline Rd, Southgate, MI 48195 Phone: 734-281-4197 Fax: 734-282-0093 |
News Archive
"Malaria prevention advocates say many lives can be saved by removing taxes and tariffs from essential commodities used to fight the disease," VOA News reports. A decade ago, African leaders promised to remove tariffs on products used to fight malaria, but only six countries have actually done so, according to the Malaria Taxes and Tariffs Advocacy Project, which held a meeting in Geneva on Wednesday, Reuters reports.
Aperio Technologies, Inc., a global leader in digital pathology for the healthcare and life sciences industry is pleased to announce that SecondSlideā¢, its newly launched digital slide sharing service for pathology, has been incorporated as one of the vendor solutions in the College of American Pathologists (CAP) prototype of the Diagnostic Work Station (DWS), a collaborative and heterogeneous vendor-neutral environment.
A commonplace electroencephalography (EEG) test may hold the key to predicting whether a person will respond to certain prescribed drugs, particularly those related to psychiatric conditions.In a study to be published by Clinical Neurophysiology, and now posted online, engineering and health sciences researchers at McMaster University applied machine learning to EEG patterns and successfully predicted how patients with schizophrenia would respond to clozapine therapy.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, is pleased to announce that the company has been awarded $245,000, the maximum amount given for a grant under the US Qualifying Therapeutic Discovery Project (QTDP) Program.
The first scan of the entire human genetic code has revealed that developing bipolar disorder may to some extent depend on the combined effects of variations in many different genes in the brain, none of which is powerful enough to cause the disease by itself.
› Verified 2 days ago